PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+9.84%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$4.03B
AUM Growth
+$4.03B
(+18%)
Cap. Flow
+$347M
Cap. Flow
% of AUM
8.62%
Top 10 Holdings %
Top 10 Hldgs %
32.52%
Holding
106
New
17
Increased
37
Reduced
18
Closed
19
Top Buys
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$126M |
| 2 |
Centene
CNC
|
$85.6M |
| 3 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$79.2M |
| 4 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$59.9M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$58.1M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$313M |
| 2 |
Universal Health Services
UHS
|
$91.1M |
| 3 |
Pacira BioSciences
PCRX
|
$87.8M |
| 4 |
McKesson
MCK
|
$72.1M |
| 5 |
Alibaba
BABA
|
$58.5M |
Sector Composition
| 1 | Healthcare | 41.83% |
| 2 | Technology | 15.77% |
| 3 | Communication Services | 6.66% |
| 4 | Consumer Discretionary | 5.76% |
| 5 | Financials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTLA
1
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $274M | 5.39% | 5,078,146 +2,332,304 | +85% | +$126M |
|
2
Puma Biotechnology
PBYI
$254M
| $164M | 3.22% | 1,369,579 -312,579 | -19% | -$37.4M |
|
3
Elevance Health
ELV
$71.8B
| $120M | 2.36% | 632,321 +77,005 | +14% | +$14.6M |
|
|
AERI
4
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $117M | 2.3% | 2,413,461 +665,421 | +38% | +$32.3M |
|
|
BPMC
5
DELISTED
Blueprint Medicines
BPMC
| $113M | 2.23% | 1,629,086 +342,636 | +27% | +$23.9M |
|
6
Edwards Lifesciences
EW
$47.8B
| $113M | 2.23% | 1,037,424 +422,613 | +69% | +$46.2M |
|
7
GoDaddy
GDDY
$20.5B
| $108M | 2.12% | 2,482,695 +375,052 | +18% | +$16.3M |
|
8
Baxter International
BAX
$12.7B
| $103M | 2.03% | 1,642,668 +462,086 | +39% | +$29M |
|
9
Meta Platforms (Facebook)
META
$1.86T
| $101M | 1.98% | 588,286 +282,087 | +92% | +$48.2M |
|
10
Abbott
ABT
$231B
| $96.1M | 1.89% | 1,800,968 +698,187 | +63% | +$37.3M |
|
|
ACOR
11
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $95.8M | 1.88% | 4,052,289 +1,464,132 | +57% | +$34.6M |
|
12
Amazon
AMZN
$2.44T
| $90.7M | 1.78% | 94,332 +33,920 | +56% | +$32.6M |
|
13
Salesforce
CRM
$245B
| $89.3M | 1.75% | 955,567 +506,867 | +113% | +$47.4M |
|
|
14
Centene
CNC
$14.3B
| $85.6M | 1.68% | +884,325 | New | +$85.6M |
|
15
Alphabet (Google) Class A
GOOGL
$2.57T
| $84.5M | 1.66% | 86,784 +45,406 | +110% | +$44.2M |
|
16
Cigna
CI
$80.3B
| $79.9M | 1.57% | 427,374 +63,129 | +17% | +$11.8M |
|
|
AGN.PRA
17
DELISTED
Allergan plc.
AGN.PRA
| $79.2M | 1.56% | +107,410 | New | +$79.2M |
|
18
JD.com
JD
$44.1B
| $78.6M | 1.55% | 2,058,588 +1,215,887 | +144% | +$46.4M |
|
19
Microsoft
MSFT
$3.77T
| $78M | 1.53% | 1,046,867 -128,436 | -11% | -$9.57M |
|
|
ATVI
20
DELISTED
Activision Blizzard Inc.
ATVI
| $71.5M | 1.4% | 1,107,904 +614,128 | +124% | +$39.6M |
|
|
ZAYO
21
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $69.5M | 1.36% | 2,017,797 +928,728 | +85% | +$32M |
|
|
MYOK
22
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $69.3M | 1.36% | 1,616,954 -52,570 | -3% | -$2.25M |
|
|
JUNO
23
DELISTED
Juno Therapeutics, Inc.
JUNO
| $65.1M | 1.28% | 1,450,607 +1,335,912 | +1,165% | +$59.9M |
|
|
24
Alibaba
BABA
$322B
| $62.9M | 1.24% | 364,341 -338,705 | -48% | -$58.5M |
|
25
ServiceNow
NOW
$190B
| $62M | 1.22% | 527,190 -91,546 | -15% | -$10.8M |
|